TruthArchive.ai - Related Video Feed

The Pfizer vaccine has undergone standard clinical trials and received provisional authorization in New Zealand. It is not considered to be in a trial period anymore. With hundreds of millions of doses administered worldwide, there have been no alarming or unexpected findings. The evidence gathered from these vaccinations aligns with what was observed during the clinical trials and in other countries.

The speaker emphasizes the lengthy process of developing a safe and effective vaccine, usually taking 10 to 25 years. They mention a potential safety issue with coronavirus vaccines, where immunization may lead to immune enhancement when exposed to the virus. This phenomenon has been observed in laboratory animals. Despite this concern, the speaker expresses enthusiasm for the approval of the second vaccine, stating that if enough Americans get vaccinated, virus transmission could be halted. They also mention the availability of new boosters, recommending anyone who is safe to get them for added protection.

Vaccines are seen as magical but expectations should be tempered. Pfizer's vaccine is 95% effective, but efficacy drops over time. Boosters may be needed annually. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but we must adapt.

Vaccines must be carefully studied to ensure they do not worsen infections. Past vaccines, like the respiratory syncytial virus vaccine for children, have unexpectedly made things worse. Similarly, an HIV vaccine increased infection risk in some cases. It's crucial to conduct thorough studies in high-risk populations to understand how vaccines truly impact infections before widespread use.

For the AstraZeneca vaccine, the range of efficacy in trials is based on various dosing intervals. The TGA will assess the best dosing interval for optimal efficacy in preventing severe disease. Importantly, early data suggests AstraZeneca may also effectively prevent disease transmission, which is crucial, especially for healthcare workers, in reducing outbreaks. While it's early and not peer-reviewed, there's a feeling that it significantly prevents transmission. We're still learning about the longevity of the vaccine's effects. The reported efficacy primarily focuses on preventing severe disease, where both vaccines show promise. The key is whether these vaccines prevent severe outcomes like death from COVID. Initial expectations were not necessarily to prevent infection, although there's emerging evidence suggesting potential reduction in transmission. Vaccine approval requires demonstrating a reduction in severe disease, which is the main focus at this stage.

Vaccine development typically takes 10 to 25 years, with the fastest recorded time in the U.S. being around 3 to 4 years. This timeline reflects the necessary clinical testing to ensure safety and efficacy. The development cycle for COVID-19 vaccines aligns closely with previous vaccine timelines, showing only modest variations. It's important for people to understand this process to alleviate concerns about the COVID-19 vaccines.

There is a new mRNA COVID-19 vaccine, but there is no evidence to support its effectiveness or safety in human trials. Additionally, several studies from different countries suggest that these vaccines may actually increase the risk of contracting COVID-19 over time. This is concerning and not a typical outcome.

Many people who have received mRNA injections for COVID-19 may die within 3 to 5 years, even with just one dose. These mRNA vaccines were rushed into clinical trials without going through the usual testing phases. Normally, vaccines would go through phase one, phase two, and phase three trials, but these vaccines skipped phase two and went straight to phase three, which involves injecting the entire population. More than 60,000 people have died during these trials, and adverse events such as heart problems and organ failure have been reported. This is a dangerous experiment happening in real time on real people, including children and pregnant women. It is important to be honest and inform people about the risks involved.

Scientists are increasingly skeptical about the feasibility and safety of developing an AIDS vaccine. The concern lies in the lengthy testing process required to ensure its effectiveness and potential risks. Initially, a small group of individuals would be administered the vaccine, and if no adverse effects are observed after a year, it would be expanded to 500 people. After another year without complications, the vaccine would be given to thousands. However, the worry is that it could take up to 12 years for any serious issues to arise. This uncertainty raises doubts about the viability of creating an AIDS vaccine.

Many are surprised to learn that the vaccines did not undergo traditional clinical trials. Initially, they were manufactured using PCR for 44,000 people, but when scaling up, the process was deemed too costly and was replaced with DNA from E. Coli, which also introduced endotoxins. In pharmaceutical manufacturing, the process is crucial; changing it typically requires new trials. The EMA requested a new trial with 252 patients, but the data was never provided, and it was considered too late since vaccinations had already begun. Thus, the rationale for conducting the trial became irrelevant.

Trump gave Moderna's COO a billion-dollar check to develop a vaccine quickly, bypassing FDA regulations. Human trials began after testing on mice. Many doubted the speed and safety of the process, but the vaccine was developed in 6 months. Concerns were raised by vaccine experts about the rushed development.

Developing an effective and safe vaccine takes around 10 to 25 years, with the current record in the US being 3 to 4 years. The timeline for COVID-19 vaccines follows a similar progression as other vaccines. There are some minor differences, but overall, the development cycle is similar. It's important for people to understand this if they have concerns about taking COVID-19 vaccines.

Scientists are increasingly skeptical about the feasibility and safety of developing an AIDS vaccine. The concern lies in the lengthy testing process required to ensure its effectiveness and safety. Initially, a small group of individuals would receive the vaccine, and if no adverse effects are observed after a year, it would be administered to 500 people. If another year passes without any issues, the vaccine would be given to thousands. However, the worry is that it could take up to 12 years for serious problems to arise. This uncertainty raises questions about the viability of creating an AIDS vaccine.

There have been no concerning long-term side effects of the vaccine so far. The vaccine has only been in use for about a year, and we haven't seen any alarming issues with other vaccines that have been used for a long time. While we can't say for certain what might happen after several years, there is no scientific reason to believe that problems would suddenly arise. Although the vaccine is new, we have no plausible reason to expect any issues in the future.

Vaccines are seen as magical, but expectations may need to be lowered. Pfizer's vaccine is 95% effective, but efficacy rates can fluctuate. Protection may only last a year, requiring annual shots. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but there is hope for improvement in the next 5 years.

There's a lot of discussion about when the vaccine will be available. I'm hopeful for an early autumn readout on its effectiveness, which depends on the number of infection cases in the trial population. This will help determine if the vaccinated group is protected. However, these vaccines may not completely eliminate infections; they might only be effective in about 60 to 70% of cases. Regulators will need to carefully assess the results before approval, so there will be a delay between trial outcomes and vaccine availability. It's also important to maintain the integrity of regulatory decisions, as any undermining of their legitimacy is counterproductive. Thank you for having me.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus, attenuated, or killed. Often, just a piece of the virus or the spike is used, eliminating the risk of causing disease. A promising new method is the RNA vaccine, which uses instructions to make the spike's shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible worldwide, which will end the pandemic.

Developing a safe and effective vaccine typically takes 10 to 25 years, with the fastest in the US being around 3 to 4 years. The timeline for COVID-19 vaccines is similar to other vaccines, with some minor differences. This should reassure those hesitant about getting vaccinated.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus, attenuated, or killed, or just a piece of the virus or the spike. A promising new method is the RNA vaccine, which uses RNA and DNA to provide instructions to make the spike shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible to everyone, which is how the pandemic will end.

The White House blames a few bad actors for spreading online misinformation. They say that misinformation on social media is harmful and can have long-term consequences. Developing a safe and effective vaccine takes time, usually around 10 to 25 years, and requires thorough clinical testing. The timeline for COVID-19 vaccines is similar to that of other vaccines.

Developing a vaccine is crucial to controlling the pandemic. Normally, it takes about five years to create a new vaccine, including testing for safety and effectiveness. However, efforts are being made to compress this timeline to around 18 months. The RNA platform shows promise in speeding up production. Ensuring a vaccine's effectiveness and safety, especially for older individuals, is challenging. We must avoid compromising safety while increasing efficacy. Decision-making regarding the use of a new vaccine will be based on limited data to expedite progress. Supporting the development of the most promising candidates, building production facilities, and conducting safety testing require a global collaborative effort. Our foundation is heavily involved in funding vaccines, including for developing countries. It's encouraging to see various medications emerging, such as Moderna, CureVac, Stamovi, and Logovac, which require investment.

Vaccines can sometimes have unexpected effects. In some cases, vaccinating someone against a disease can actually make them more susceptible to the infection. This has happened before with vaccines like the respiratory syncytial virus vaccine in children and an HIV vaccine that was tested a few years ago. So, it's important to carefully evaluate the safety of vaccines before administering them.

It is important to consult with your doctor or a trusted person to understand the risks and frequency of side effects associated with vaccination. While these side effects do exist, they are very rare and mostly mild. Within 48 hours of vaccination, one may experience a headache or a slight fever. With this information, we can have confidence in the vaccination process.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus (attenuated), a killed virus, or just a piece of the virus, like the spike. A promising new method is the RNA vaccine, which uses instructions to make the spike's shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible worldwide, which is how the pandemic will end.

The trial data for the process 2 vaccine was limited, with only 252 people tested. Independent researchers confirmed this. The study was added during the phase three trials and was not intended to be meaningful. The comparison study between process 1 and process 2 doses was never conducted, despite initial plans. Only 4 people were tested for antibody response, and they were all under 23 years old. The study lacked clinical data and was approved for emergency use without sufficient evidence. The use of live cells in the manufacturing process added complexity and risk. Similar issues occurred with the swine flu vaccine in 2009. There was no public notification about the changes made to the vaccine.